Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Adalimumab
Humira
Not routinely available
SMC (1305/18)
15/01/2018
Indication
Treatment of paediatric chronic non-infectious anterior uveitis in patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.
Therapeutic Area
Eye
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
40mg/0.4mL pre-filled syringe and pre-filled pen / 40mg/0.4mL 40mg/0.8mL vial for paediatric use
Comments
None
Link to Advice
Advice Published
15/01/2018
SMC Submission Type
Non submission
SMC Status
Not recommended